Sign in

Kamila Naxerova

@naxerova.bsky.social
146 followers 65 following 25 posts

Naxerova lab at @HMSGenetics. We study somatic evolution and cancer genetics.

PostsRepliesMedia
Reposted by Kamila Naxerova
Craig Anderson @craigandersn.bsky.social · 01/10/2026
You can now register for Mutations in time and space 2027 🎉🎉🎉🎉🎉🎉 www.embl.org/about/info/c... 🎉🎉🎉🎉🎉🎉 This time we're in beautiful Heidelberg over 15 - 18 June. Along with a stellar cast of invited speakers, there are a ton of slots for submitted abstracts. Please do come along and take part :-)
embl.org
Mutations in time and space
184
Kamila Naxerova @naxerova.bsky.social · 18/09/2026
@r-rahbari.bsky.social is on fire! 🔥
010
Kamila Naxerova @naxerova.bsky.social · 24/08/2026
A special note for future postdocs interested in mouse hematopoietic evolution: we have an exciting position co-supervised by David Scadden and Matthias Nahrendorf. Great project with wonderful mentors—please reach out if you’d like to learn more!
010
Kamila Naxerova @naxerova.bsky.social · 24/08/2026
Finishing your PhD or looking for a post-bac research position? We’re recruiting postdocs and research technicians to study somatic evolution! Come do interdisciplinary science in a friendly, collaborative environment at @harvardmed.bsky.social Genetics www.naxerova.hms.harvard.edu/contact
naxerova.hms.harvard.edu
Join Us — Naxerova Lab
035
Reposted by Kamila Naxerova
Sarah Aitken @s-j-aitken.bsky.social · 27/07/2026
🧬NEW PAPER🧬 To what extent is cancer development deterministic? Does the germline genome affect that predictability? Find out in our #StrainDifferences paper @nature.com "Genetic background sets the trajectory of experimental cancer evolution" www.nature.com/articles/s41... 🧵[1/14]
nature.com
Genetic background sets the trajectory of experimental cancer evolution - Nature
Experimentally replaying tumour evolution in divergent mouse strains reveals the importance of interactions between genetic ancestry and acquired cancer-driving mutations in shaping the earliest stage...
14717
Reposted by Kamila Naxerova
Dmitri Petrov @petrovadmitri.bsky.social · 15/07/2026
Cannot be more excited about the lineup for the inaugural Function of Evolving Systems GRC conference I am co-organizing with the amazing Joy Bergelson. Less than a month away: August 9 - 14, 2026. Still a few spots left! And do check out the amazing list of speakers: www.grc.org/function-of-...
grc.org
2026 Function of Evolving Systems Conference GRC
The 2026 Gordon Research Conference on Function of Evolving Systems will be held in Waterville Valley, New Hampshire. Apply today to reserve your spot.
43926
Reposted by Kamila Naxerova
Dan Landau @landau.bsky.social · 22/06/2026
New results with tree reconstruction of glioma progression. Phylodynamics applied to primary patient samples allow to define how progression is linked to changes in differentiation hierarchies. We ❤️ trees!
082
Kamila Naxerova @naxerova.bsky.social · 16/06/2026
Please join us in NH (perfect place to be in August!) for this inspiring conference organized by @petrovadmitri.bsky.social and Joy Bergelson. Very interdisciplinary, so I look forward to learning tons of new concepts. www.grc.org/function-of-...
grc.org
Function of Evolving Systems - Gordon Research Conferences
GRC presents Function of Evolving Systems, a conference on .
064
Reposted by Kamila Naxerova
Dan Landau @landau.bsky.social · 04/06/2026
Exciting breakthrough technology from the lab, now live in @cellcellpress.bsky.social ! Instead of cutting the genome where proteins bind (e.g., Cut&Tag), D&D-seq scars the DNA with a deaminase, allowing single cell genome mapping of TFs and chromatin remodellers!
212851
Reposted by Kamila Naxerova
Martin Taylor @mstaylor.bsky.social · 26/05/2026
Interested in DNA damage and the mechanisms of mutagenesis? We are hiring post-doctoral scientists as part of the amazing CAUSE Cancer Grand Challenge team. Biochemistry, genomics and computational biology... tinyurl.com/yc5xs3wa tinyurl.com/4unu5uu9 CAUSE www.cancergrandchallenges.org/cause
Cancer Grand Challenges - Team CAUSE logo
088
Kamila Naxerova @naxerova.bsky.social · 06/05/2026
A gene is recurrently mutated in cancer. But do these mutations really cause the disease? Or are they merely selected during normal tissue evolution? Postdoc D. Cheek had the creative idea to use patient ages to try and answer this question. Read new paper out here: www.nature.com/articles/s41...
nature.com
Age distinguishes selection from causation in cancer genomes - Nature Genetics
Mutations may be enriched in tumor samples because they promote carcinogenesis or because they promote clonal expansions in healthy tissue. This study mathematically disentangles these two possibiliti...
0134
Reposted by Kamila Naxerova
Jamal-Hanjani Lab @jamal-hanjani-lab.bsky.social · 29/04/2026
Excited to share our ‘Evolutionary characterization of lung cancer metastasis’ in #TRACERx & #PEACE, published today in @nature.com in collaboration with @charlesswanton.bsky.social @nickymcgranahan.bsky.social @zaccasimo.bsky.social at @ucl.ac.uk & @crick.ac.uk. www.nature.com/articles/s41...
nature.com
Evolutionary characterization of lung cancer metastasis - Nature
DNA-sequencing data from primary tumours and paired metastases from participants in the TRACERx lung study and PEACE autopsy programme are used to analyse the metastatic diversity of advanced non-smal...
22514
Reposted by Kamila Naxerova
Nuria Lopez-Bigas @nlbigas.bsky.social · 15/04/2026
Tumor promotion through the lens of evolution This review grew out of many long conversations, shared ideas, and lively discussions It has been a real pleasure to think together with Allan, Paul, Eve, and Abel about how tumours develop and how carcinogens shape cancer risk rdcu.be/fdC2J
rdcu.be
Tumour promotion through the lens of evolution
Nature - This Review revisits tumour initiation and promotion in light of clonal diversity and the presence of cancer driver mutations in normal tissues, aiming to understand mechanisms that enable...
13314
Reposted by Kamila Naxerova
Inigo Martincorena @imartincorena.bsky.social · 15/04/2026
Excited to share our latest work in Nature. Applying single-molecule and single-cell DNA sequencing methods, we uncover an extraordinary landscape of somatic mutations in immune checkpoint genes in autoimmune B cells, suggesting that somatic mutations may be key to autoimmunity [1/n] rdcu.be/fdqbr
rdcu.be
Polyclonal selection of immune checkpoint mutations in thyroid autoimmunity
Nature - Polyclonal selection of immune checkpoint mutations in thyroid autoimmunity
14720
Reposted by Kamila Naxerova
The Mark Foundation for Cancer Research @themarkfdn.bsky.social · 08/04/2026
Did you catch our news during #MarkSymposium? We’re accepting applications for our 2026 Emerging Leader Awards, now offering $1 million over 4 years & open to investigators worldwide! Submit your LOI by April 30: themarkfoundation.org/emerging-lea... #ResearchFunding
themarkfoundation.org
Emerging Leader Award | The Mark Foundation for Cancer Research
011
Reposted by Kamila Naxerova
Dmitri Petrov @petrovadmitri.bsky.social · 25/03/2026
The conference is quickly filling up! Don't wait to sign up. We also received some funding and can offer fellowships to graduate students and postdocs. Won't cover the whole cost but will certainly make it much easier!
034
Reposted by Kamila Naxerova
Vladimir (Vova) Seplyarskiy @vseplyarskiy.bsky.social · 06/03/2026
📢 Postdoc position available in my lab We study mutagenesis, population genetics, and Mendelian genomics—linking the origins of mutations to their biological and disease consequences. Details about research directions: labs.utsouthwestern.edu/seplyarskiy-... Please reach out if interested.
labs.utsouthwestern.edu
Research | Seplyarskiy Lab | UT Southwestern, Dallas, Texas
012
Reposted by Kamila Naxerova
Maria Alcolea @mariapalcolea.bsky.social · 04/03/2026
🚨 New paper from our lab just published in Nature🚨 www.nature.com/articles/s41... Discover how 🌱 tumour formation is shaped by tissue context from the very beginning. Cancer is not driven by genetics alone ✨Fantastic team led by Greta Skrupskelyte, Eduardo Rojo, @hariajith.bsky.social
911440
Reposted by Kamila Naxerova
Vijay G. Sankaran @bloodgenes.bsky.social · 15/02/2026
Check out this important advance in mitochondrial 🧬 lineage tracing by @gaoteng.bsky.social and @wengchen.bsky.social from our group, in collaboration with @jswlab.bsky.social 👇👇
0173
Kamila Naxerova @naxerova.bsky.social · 30/01/2026
Please come join us - so excited for this conference!
042
Reposted by Kamila Naxerova
Irving Institute for Cancer Dynamics @cancerdynamics.bsky.social · 27/01/2026
IICD welcomes next David Cheek from @harvard.edu on Feb. 11 at 2 PM, as part of our seminar series. Dr. Cheek will discuss causation in cancer genomes. Register: cancerdynamics.columbia.edu/events/iicd-... cc: @harvardmed.bsky.social @naxerova.bsky.social
David Cheek's Seminar
011
Reposted by Kamila Naxerova
The Mark Foundation for Cancer Research @themarkfdn.bsky.social · 14/01/2026
📢 Announcing The Mark Foundation 2026 Emerging Leader Award winners! 📢 We are committing $3.75 million to 5 visionary early-career scientists poised to lead the next generation of oncology breakthroughs. We can't wait to see their impact! themarkfoundation.org/2026/01/2026...
2103
Kamila Naxerova @naxerova.bsky.social · 13/01/2026
Very nice! www.biorxiv.org/content/10.6...
biorxiv.org
Ultra-deep duplex sequencing reveals unique features of somatic evolution in the normal tissues of a family with Li-Fraumeni syndrome
Li-Fraumeni syndrome (LFS) is caused by germline pathogenic variants in TP53 which predispose carriers to early onset cancer across multiple tissues. While genomically profiling those cancers has reve...
000
Reposted by Kamila Naxerova
Craig Anderson @craigandersn.bsky.social · 13/01/2026
The abstract deadline for Mutations in Time and Space 2026 closes in 3 weeks time. Sign up here: coursesandconferences.wellcomeconnectingscience.org/event/mutati... As well as thrilling science, the programme includes dinner at the beautiful King's College in Cambridge. @eventswcs.bsky.social
coursesandconferences.wellcomeconnectingscience.org
053
Reposted by Kamila Naxerova
Dan Landau @landau.bsky.social · 07/01/2026
Happy new year/paper! A new tech (scG2P) maps genotype (DNA) to phenotype (RNA) in single cells, bringing together the worldviews of genetic & transcriptional heterogeneity. With scG2P we define how mosaicism drivers increase clonal fitness in the aging esophagus aacrjournals.org/cancerdiscov...
1208
Reposted by Kamila Naxerova
bioRxiv Genomics @biorxiv-genomic.bsky.social · 30/12/2025
Somatic and germline mutational processes across the tree of life www.biorxiv.org/content/10.64898/20…
12114
Reposted by Kamila Naxerova
Trevor Graham @trevorgraham.bsky.social · 17/11/2025
@kevinmonahan.bsky.social & I have an open clinical #PhD position between @stmarkshospital.bsky.social and @icr.ac.uk If you're interested in the biology of pre-cancer in the bowel & want to translate biology for cancer prevention this one could be for you... funded by the brilliant #40tude
065
Reposted by Kamila Naxerova
Craig Anderson @craigandersn.bsky.social · 14/11/2025
Come to Germany and do a PhD with DKFZ. You'll be supported by an international community doing amazing science in a fantastic place. I joined the DKTK from the UK 3 months ago and couldn't be happier with how easy it has been fitting in. The quality of work here is phenomenal and you should apply!
054
Reposted by Kamila Naxerova
Trevor Graham @trevorgraham.bsky.social · 05/11/2025
New @natgenet.nature.com paper from the brilliant @eszterlakatos.bsky.social presents evidence that chromatin alterations disrupt antigen presentation & neoantigens in colorectal cancer. Also that immune escape is part of the "Big Bang", at the outset of CRC growth. www.nature.com/articles/s41...
nature.com
Epigenetically driven and early immune evasion in colorectal cancer evolution - Nature Genetics
This study nominates immune escape as an early event in colorectal cancer and shows how this can be driven through both genetic and epigenetic changes.
23011
Reposted by Kamila Naxerova
Martin Taylor @mstaylor.bsky.social · 04/11/2025
The exciting next instalment of Mutations in Time and Space... Open for registration now
077
Reposted by Kamila Naxerova
Ilya Marritz @ilyamarritz.bsky.social · 01/11/2025
WEEKEND LISTEN This year, the Trump admin threw everything it had at the nation's oldest and richest university 3 Harvard profs tell the story of what they saw @naxerova.bsky.social @ryanenos.bsky.social & Kit Parker www.wnycstudios.org/podcasts/otm...
wnycstudios.org
S2 - Episode 1: The Harvard Plan | On the Media | WNYC Studios
The Harvard Plan - our collaboration with the Boston Globe, is back! In episode one, we hear what unfolded at Harvard from Donald Trump’s inauguration to convocation 2025. Three main ...
0187
Reposted by Kamila Naxerova
Dan Landau @landau.bsky.social · 14/10/2025
Big, beautiful trees!! SMART-PTA for whole-genome+transcriptome on thousand of single cells from the normal human esophagus 🤯 Massively scaling up the power of scWGS to build deep phylogenies and chart somatic evolution from birth throughout life. www.biorxiv.org/content/10.1...
14815
Reposted by Kamila Naxerova
Trevor Graham @trevorgraham.bsky.social · 14/10/2025
We have two fantastically well-funded #PhD studentships available through the @evomg-dn.bsky.social #EU doctoral network (led by brilliant @mirimiam.bsky.social, @crg.eu). These enable students to move to the UK and come and work with us @icr.ac.uk to exploit #cancer #evolution for patient benefit.
11814
Reposted by Kamila Naxerova
Nuria Lopez-Bigas @nlbigas.bsky.social · 08/10/2025
🚨 New paper alert! Sex and smoking bias in the selection of somatic mutations in human bladder www.nature.com/articles/s41... by @raquelbmi.bsky.social, @ferriol.bsky.social et al (in collaboration with Rosana Risques lab in @uwmedicine.bsky.social)
nature.com
Sex and smoking bias in the selection of somatic mutations in human bladder - Nature
Sex bias and association with smoking history identified in the landscape of driver mutations and clonal expansions in normal human bladder tissue may explain the higher bladder cancer risk in men and smokers.
27029
Reposted by Kamila Naxerova
Inigo Martincorena @imartincorena.bsky.social · 08/10/2025
Our latest work is out in Nature today. In this paper, we introduce an improved version of NanoSeq, a duplex sequencing protocol with <5 errors per billion bp in single DNA molecules, and use it to study the somatic mutation landscape of oral epithelium in >1000 people www.nature.com/articles/s41...
nature.com
Somatic mutation and selection at population scale - Nature
A new version of nanorate DNA&nbsp;sequencing, with an&nbsp;error rate&nbsp;lower than five errors&nbsp;per billion base pairs&nbsp;and compatible with whole-exome and targeted capture, enables epidemiological-scale studies of somatic mutation and selection&nbsp;and&nbsp;the generation of high-resolution&nbsp;selection&nbsp;maps across coding and non-coding sites for many genes.
59147
Reposted by Kamila Naxerova
Dmitri Petrov @petrovadmitri.bsky.social · 15/09/2025
Very excited to see this work in press! I think there is a reason to believe that this is a common means of stabilizing large-effect polymorphisms in general and might be an important reason for why diploidy is so common. news.stanford.edu/stories/2025...
news.stanford.edu
Classic recessive-or-dominant gene dynamics may not be so simple
New fruit fly research provides the first direct evidence of “dominance reversal,” revealing why pesticide resistance is so hard to eliminate in changing environments.
16829
Reposted by Kamila Naxerova
EMBL-EBI @ebi.embl.org · 12/08/2025
Welcome @timcoorens.bsky.social ‪ ‬🇳🇱, our new Research Group Leader. Find out how Tim’s group is exploring using large-scale single-cell and spatial data to trace cell lineages, understand cancer origins, and uncover how mutations drive disease. www.ebi.ac.uk/about/news/p... 🖥️🧬
ebi.ac.uk
Welcome: Tim Coorens
EMBL-EBI’s newest Research Group Leader is investigating how somatic mutations reveal the hidden histories of human cells.
24910
Reposted by Kamila Naxerova
Thomas R. Cox @trcox.matrixandmetastasis.com · 08/08/2025
@naxerova.bsky.social
001
Kamila Naxerova @naxerova.bsky.social · 18/07/2025
Thank you for thinking of us. It’s been a rough ride. My lab lost two R01s, and as painful as that is for us, we are just one drop in a big bucket of terminations. HMS is doing everything they can to help us in the short term, but we need long term solutions - please keep up the conversation.
030
Reposted by Kamila Naxerova
Craig Anderson @craigandersn.bsky.social · 18/07/2025
Today is my last day at the @uoe-igc.bsky.social in Edinburgh, as I'm starting my own lab in Munich as part of the German Cancer Consortium (DKTK), DKFZ and the LMU. I'll continue to focus on DNA damage and mutagenesis to determine their role in somatic evolution and disease.
4183
Kamila Naxerova @naxerova.bsky.social · 12/07/2025
Very cool!
000
Reposted by Kamila Naxerova
Hao Zhu Lab at UT Southwestern @haozhulab.bsky.social · 12/07/2025
Introducing 2 new papers from my lab on somatic mutations in liver disease. The 1st is about a mutated gene that leads to improved clone fitness and organismal health (CIDEB). The 2nd is about a mutated gene that leads to improved clone fitness but worse overall health (TBX3). 1/8
2135
Reposted by Kamila Naxerova
Tim Coorens @timcoorens.bsky.social · 03/07/2025
The cells in our bodies constantly acquire mutations. But what are the patterns of mutations across tissues? How do mutations in normal cells lead to cancer and disease? These are questions we will tackle within the Somatic Mosaicism across Human Tissues (SMaHT) Network, now described in @nature.com
nature.com
The Somatic Mosaicism across Human Tissues Network - Nature
The Somatic Mosaicism across Human Tissues Network aims to create a reference catalogue of somatic mosaicism across different tissues and cells within individuals.
1349
Reposted by Kamila Naxerova
Jamie Blundell @jamie-blundell.bsky.social · 03/07/2025
Delighted to share our latest on longitudinal methylation dynamics preceding cancer. Epigenetic signs of AML appear in blood DECADES before Dx. 👉 Early cancer detection 👉 Methylation drivers 👉 Epimutation rates 👉 CpG lineage tracing www.biorxiv.org/content/10.1...
12313
Reposted by Kamila Naxerova
Dmitri Petrov @petrovadmitri.bsky.social · 27/06/2025
We are recruiting students who are thinking of applying to Biology PhD programs this fall to apply for the Stanford Biology Preview Program. Please spread the word!
179
Reposted by Kamila Naxerova
Martin Taylor @mstaylor.bsky.social · 15/01/2025
To what extent is cancer development deterministic and predictable..? Does the germline genome affect that predictability...? Preprint: www.biorxiv.org/content/10.1...
Manuscript logo, phylogenetic tree of mouse strains with different but highly reproducible patterns of cancer evolution. Demonstrated by rerunning cancer evolution in a controlled system.
2178
Kamila Naxerova @naxerova.bsky.social · 20/06/2025
www.votervoice.net/mobile/AACR/...
votervoice.net
Urge Congress to Support NIH and Protect Medical Research
Protect the Future of Cancer Research: Tell Congress to Reject NIH CutsThe American Association for Cancer Research (AACR) urges you to take immediate action to defend the National Institutes of Healt...
000
Reposted by Kamila Naxerova
Vladimir (Vova) Seplyarskiy @vseplyarskiy.bsky.social · 04/06/2025
🚨 Looking for postdocs! I'm starting my lab at UT Southwestern this September. If you're interested in: 🧬 Somatic & germline mutagenesis 🐭 Evolution of mutation processes 🧠 Adjacent areas like Mendelian genomics & population genetics—please consider joining. Formal ad coming soon. DM me!
064
Kamila Naxerova @naxerova.bsky.social · 21/05/2025
Social media grump Kamila has finally made it onto Bluesky! Please check out my new perspective on metastasis evolution in @natrevcancer.nature.com if you need a reprieve from the news. I tried my best to develop some new conceptual thoughts here, you be the judge whether I succeeded.
0124
Reposted by Kamila Naxerova
Vijay G. Sankaran @bloodgenes.bsky.social · 20/05/2025
www.forbes.com/sites/johndr...
forbes.com
Trump’s NIH And NSF Cuts Estimated To Cost The U.S. Economy $10 Billion Annually
Economists find public R&D drives U.S. productivity growth — and pays for itself
044